Artelo Biosciences
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -2,421 | -2,834 | -3,789 | -3,009 |
EBIT | -2,421 | -2,834 | -4,072 | -3,009 |
Net Income | -2,427 | -2,958 | -4,166 | -3,120 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -5,033 | -1,191 | -2,911 | -3,498 |
Cash | 4,198 | 10,273 | 600 | 1,720 |
Basic Shares | 301 | 82 | 261 | 262 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -12,539 | -9,826 | -9,289 | -10,078 |
EBIT | -12,685 | -10,108 | -9,930 | -10,287 |
Net Income | -12,879 | -9,826 | -9,289 | -10,083 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -8,520 | -8,350 | -8,207 | -8,008 |
Cash | 600 | 2,338 | 2,815 | 6,888 |
Basic Shares | 261 | 1,074 | 986 | 157 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.89 |
2026-03-31 | -$36.02 |
2025-12-31 | -$0.12 |
2025-09-30 | -$11.91 |